Skip to content

Matthew Appleton

Partner

London

Appleton Matthew
Matthew Appleton

Partner

London

Matthew is a Corporate/M&A Partner with a particular focus on the Life Sciences and the Consumer & Retail sectors. He has significant experience advising clients on a wide variety of matters, including private M&A, joint ventures, public takeovers, restructurings and listing requirements. 

Matthew has specific expertise in highly complex cross-border M&A transactions.  He regularly advises clients on M&A auction processes, executing successful transactions both for sellers and for buyers.

"Excellent - pragmatic and thorough." - Legal 500

Experience includes advising:

Asahi on its USD11.3bn acquisition of Carlton & United Breweries, the Australian arm of Anheuser-Busch InBev. 

Asahi Group
on its EUR7.30bn acquisition of the Central & Eastern European business of SABMiller by way of auction. 

Asahi Group
on its EUR2.55bn acquisition of Peroni, Grolsch and Meantime by way of auction. 

Grünenthal
on its USD922m acquisition from AstraZeneca of prescription products Nexium in Europe and Vimovo worldwide (excluding the U.S. and Japan). 

Life Healthcare Group Holdings
on its GBP600m acquisition of Alliance Medical Group by way of auction. 

Grünenthal
on its acquisition of the global rights to the migraine medication, Zomig, from AstraZeneca for a total consideration of up to USD302m. 

GlaxoSmithKline
on the GBP1.35bn disposal of its nutritional drinks brands, Lucozade and Ribena, to Suntory Beverage & Food, the Japanese consumer goods company. 

GlaxoSmithKline
on various disposals of prescription and consumer healthcare products by way of auction.

US-headquartered global pharmaceutical company on its series A2 equity investment in a UK biotech company and related research/collaboration agreement in respect of certain antigen targets.

G Square Healthcare Private Equity
and Aribua on the sale of SARquavitae to PAI Partners. 

SSL International
on its recommended public takeover by Reckitt Benckiser for GBP2.54bn. 

IMI
on the USD1.1bn disposal of its beverage dispense and merchandising businesses to The Marmon Group, a Berkshire Hathaway company, and related return of cash to shareholders. 

Tullett Prebon
on its GPB1.4bn reverse takeover, carve-out acquisition of ICAP's global hybrid broking and information business and related issuance of consideration shares and readmission to the LSE. 

TUI AG
on its all-share merger with TUI Travel and related admission to the LSE. 

MP & Silva
and its shareholders on the sale of a majority stake in the business to Everbright and Beijing Baofeng Technology by way of auction.

Office

London

Allen & Overy LLP
One Bishops Square
London
E1 6AD

View office →

Qualifications

Professional

Admitted as solicitor, England and Wales, 2009.

Academic

BA, Law, Magdalene College, Cambridge University, 2005.